These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12191019)

  • 1. The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
    De Mazière AM; Muehlethaler K; van Donselaar E; Salvi S; Davoust J; Cerottini JC; Lévy F; Slot JW; Rimoldi D
    Traffic; 2002 Sep; 3(9):678-93. PubMed ID: 12191019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes.
    Hoashi T; Watabe H; Muller J; Yamaguchi Y; Vieira WD; Hearing VJ
    J Biol Chem; 2005 Apr; 280(14):14006-16. PubMed ID: 15695812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
    Lévy F; Muehlethaler K; Salvi S; Peitrequin AL; Lindholm CK; Cerottini JC; Rimoldi D
    Mol Biol Cell; 2005 Apr; 16(4):1777-87. PubMed ID: 15703212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition.
    Giordano F; Bonetti C; Surace EM; Marigo V; Raposo G
    Hum Mol Genet; 2009 Dec; 18(23):4530-45. PubMed ID: 19717472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coat color dilution in mice because of inactivation of the melanoma antigen MART-1.
    Aydin IT; Hummler E; Smit NP; Beermann F
    Pigment Cell Melanoma Res; 2012 Jan; 25(1):37-46. PubMed ID: 21943097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mislocalization of melanosomal proteins in melanocytes from mice with oculocutaneous albinism type 2.
    Manga P; Boissy RE; Pifko-Hirst S; Zhou BK; Orlow SJ
    Exp Eye Res; 2001 Jun; 72(6):695-710. PubMed ID: 11384158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein.
    Hoashi T; Sato S; Yamaguchi Y; Passeron T; Tamaki K; Hearing VJ
    FASEB J; 2010 May; 24(5):1616-29. PubMed ID: 20056711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.
    Basrur V; Yang F; Kushimoto T; Higashimoto Y; Yasumoto K; Valencia J; Muller J; Vieira WD; Watabe H; Shabanowitz J; Hearing VJ; Hunt DF; Appella E
    J Proteome Res; 2003; 2(1):69-79. PubMed ID: 12643545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells.
    Raposo G; Tenza D; Murphy DM; Berson JF; Marks MS
    J Cell Biol; 2001 Feb; 152(4):809-24. PubMed ID: 11266471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis.
    Jimbow K; Park JS; Kato F; Hirosaki K; Toyofuku K; Hua C; Yamashita T
    Pigment Cell Res; 2000 Aug; 13(4):222-9. PubMed ID: 10952389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorting and targeting of melanosomal membrane proteins: signals, pathways, and mechanisms.
    Setaluri V
    Pigment Cell Res; 2000 Jun; 13(3):128-34. PubMed ID: 10885669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
    Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
    Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
    Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
    Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A/MART-1.
    Song HZ; Kono M; Tomita Y
    Tohoku J Exp Med; 2009 Mar; 217(3):231-7. PubMed ID: 19282659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
    Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
    Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter.
    Kurnick JT; Ramirez-Montagut T; Boyle LA; Andrews DM; Pandolfi F; Durda PJ; Butera D; Dunn IS; Benson EM; Gobin SJ; van den Elsen PJ
    J Immunol; 2001 Aug; 167(3):1204-11. PubMed ID: 11466335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melan-A/MART-1 antigen expression in cutaneous and ocular melanomas.
    Nicotra MR; Nisticò P; Mangoni A; Di Filippo F; Marincola FM; Natali PG
    J Immunother; 1997 Nov; 20(6):466-9. PubMed ID: 9409452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
    Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides.
    Jäger E; Maeurer M; Höhn H; Karbach J; Jäger D; Zidianakis Z; Bakhshandeh-Bath A; Orth J; Neukirch C; Necker A; Reichert TE; Knuth A
    Int J Cancer; 2000 May; 86(4):538-47. PubMed ID: 10797269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.